-
Mashup Score: 1
/PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) accelerated approval of Ziihera®…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 106
/PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) accelerated approval of Ziihera®…
Source: www.prnewswire.comCategories: General Medicine News, Hem/OncsTweet-
🆕drug approval! #PrecisionMedicine 🎯 #HER2-targeted bispecific antibody ✅Zanidatamab-hrii for HER2➕(IHC 3+) Biliary Tract Cancer (BTC). Trials possible for ‘rare’ cancers like cholangiocarcinoma. More options for our patients. @OncoAlert @curecc https://t.co/0Y0aiY8rjF https://t.co/lEZTILFLQz
-
-
Mashup Score: 24Frontiers | Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer - 5 day(s) ago
Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China Background: Colorectal cancer (CRC) is one of the most commonly diagnosed advanced-stage malignancies worldwide and places a substantial burden on both the economic and social development of numerous countries. Objective: This manuscript aims to synthesize the existing evidence and explore potential avenues for future
Source: www.frontiersin.orgCategories: General Medicine News, Hem/OncsTweet-
Really enjoyed reading this article📝. #ctDNA & #LiquidBiopsies are here to stay. Colorectal cancer has been the poster child. How has the data📊 & collaborations🗺️ evolved over the years? Cool cooperation analysis👇🏽. https://t.co/1Qn974CdaK @FrontOncology @OncoAlert #CRCSM https://t.co/IroxOdte1K
-
-
Mashup Score: 24
Transplant Oncology: A Frontier in Multidisciplinary Cancer Care
Source: www.amazon.comCategories: General Medicine News, Hem/OncsTweet-
Delighted to have contributed to this book📕on Transplant Oncology. Edited by: @MaenAbdelrahim Foreword: @JimAllisonPhD 📝My chapter focuses on #LiquidBiopsies #CTCs, 🟣🟠 #ctDNA🩸🧬and beyond💡. Out now➡️Amazon/Elsevier. 📌https://t.co/d3S9vKm55i @OncoAlert @DrawImpacts https://t.co/U8jaoaaqXK https://t.co/mZfcm1C0XV
-
-
Mashup Score: 8Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | NEJM - 25 day(s) ago
Original Article from The New England Journal of Medicine — Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
@marklewismd Also, in the same session as our BESPOKE Study, the DYNAMIC-2 by @JeanneTie. From the initial DYNAMIC 1st randomized controlled trial in #ctDNA. Dynamic-2 Dr. Tie can comment better - but this one is for Rectal Cancer. #CRCSM @OncoAlert https://t.co/yV8w3DOqt0
-
-
Mashup Score: 20I got a deadly diagnosis after going to my doctor for a stomach ache - 1 month(s) ago
Brandon Arbini from California went to the doctor with mild stomach pain. His GI doctor scheduled a colonoscopy to investigate and they were shocked by what they found.
Source: www.dailymail.co.ukCategories: General Medicine News, Hem/OncsTweet-
Seeing more individuals with young-onset #colorectalcancer—many not linked to genetics. Patients in their 20s, 30s, 40s, and even teens are being diagnosed. 🙏🏾 @DailyMailUK for shedding light on this critical issue. @cityofhope @cityofhopeoc Need more🔬. https://t.co/GXbGttQifc
-
-
Mashup Score: 6Registration - ISLB 2024 - 2 month(s) ago
Register for the 6th Annual Liquid Biopsy Congress, November 23-25, 2024, Denver, Colorado, USA. Shape the future of cancer diagnostics.
Source: 2024.islb.infoCategories: General Medicine News, Hem/OncsTweet-
RT @isliquidbiopsy: Register for #ISLB24 at https://t.co/iOOIDx3ghQ Today! In Person registration grants access to all Scientific Sessions…
-
-
Mashup Score: 6Registration - ISLB 2024 - 5 month(s) ago
Register for the 6th Annual Liquid Biopsy Congress, November 23-25, 2024, Denver, Colorado, USA. Shape the future of cancer diagnostics.
Source: 2024.islb.infoCategories: General Medicine News, Hem/OncsTweet-
RT @isliquidbiopsy: Register for #ISLB24 at https://t.co/iOOIDx3ghQ Today! In Person registration grants access to all Scientific Sessions…
-
-
Mashup Score: 4Updated results from the TRANSMET trial at ESMOGI24 - OncoDaily - 5 month(s) ago
Updated results from the TRANSMET trial at ESMOGI24 / cancer, ESMO, ESMOGI24, OncoDaily, Oncology, TRANSMET
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Updated results from the TRANSMET trial at ESMOEGI24 @myESMO https://t.co/UIKmkksFZc #Cancer #ESMO #ESMOGI24 #OncoDaily…
-
-
Mashup Score: 1
Should biologics be the initial treatment for immune checkpoint inhibitor colitis?
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
@RenoHemonc @myESMO @OncoAlert @FoxtrotStudy @JenSeligmann @JCO_ASCO Very different experience in the neoadjuvant setting since we only did a single half-dose (75 mg) BOT once. No planned surgery was delayed due to any treatment AEs. When acted upon early infliximab is steroid sparing & no hospital admission. 👇🏾 @JCO_ASCO https://t.co/je8et9aF8e
-
🆕drug approval! #PrecisionMedicine 🎯 #HER2-targeted bispecific antibody ✅Zanidatamab-hrii for HER2➕(IHC 3+) Biliary Tract Cancer (BTC). Trials possible for ‘rare’ cancers like cholangiocarcinoma. More options for our patients. @OncoAlert @curecc https://t.co/0Y0aiY8rjF https://t.co/lEZTILFLQz